Document Detail


Healthcare resource utilization in the management of oesophageal adenocarcinoma.
MedLine Citation:
PMID:  11421868     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To study the natural history of oesophageal adenocarcinoma in terms of utilization of the healthcare resources and associated medical costs. METHODS: All 29 patients treated at the University of New Mexico Health Center between 1 January 1992 and 1 December 1998 for an oesophageal adenocarcinoma were included in the study. For each individual patient, all medical resources utilized, facility costs, and physician fees were retrieved from the computerized databases of the collection departments. RESULTS: During the progress of the disease, the same type of diagnostic or therapeutic procedure became necessary a number of times, and patients underwent, on average, three (range one to eight) upper gastrointestinal endoscopies, five (range one to 11) computerized tomography scans, 35 (five to 143) X-ray examinations, and 28 (three to 46) radiation therapies or 39 (10 to 74) chemotherapies. The large variation in the numbers of resources utilized was also reflected by a corresponding variation in total healthcare costs. The mean cost per patient was $48 127, ranging between $13 454 and $139 721. Facility costs comprised 88% of all costs compared to physician fees which comprised 12%. The largest cost items, in declining order, were physician encounters ($16 916), radiation plus chemotherapy ($9909 plus $4891, respectively), and pharmacy prescriptions ($7565). CONCLUSIONS: The prolonged disease process and the many diagnostic and therapeutic procedures result in complications, side-effects, inconclusive tests, or failed therapies that all markedly increase the use of healthcare resources. Because such outcomes are the rule rather than the exception, the management of oesophageal adenocarcinoma is expensive.
Authors:
A Soni; A Sonnenberg
Related Documents :
16164658 - Direct and indirect costs of nephrolithiasis in an employed population: opportunity for...
16672868 - Cost effectiveness of revision total knee arthroplasty.
10580738 - Pharmacoeconomics of antimicrobial therapy.
11276578 - Costs of asthma treatment in estonia.
12620088 - A physiological profile approach to falls risk assessment and prevention.
24432938 - Work organization and health among immigrant women: latina manual workers in north caro...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Alimentary pharmacology & therapeutics     Volume:  15     ISSN:  0269-2813     ISO Abbreviation:  Aliment. Pharmacol. Ther.     Publication Date:  2001 Jul 
Date Detail:
Created Date:  2001-06-25     Completed Date:  2001-08-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8707234     Medline TA:  Aliment Pharmacol Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  945-51     Citation Subset:  IM    
Affiliation:
The Department of Veterans Affairs Medical Center and The University of New Mexico, Albuquerque, New Mexico, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / diagnosis,  economics*,  therapy*
Adult
Aged
Antineoplastic Agents / economics,  therapeutic use
Cost of Illness
Diagnostic Imaging / economics
Esophageal Neoplasms / diagnosis,  economics*,  therapy*
Female
Health Care Costs / statistics & numerical data*
Health Services / utilization*
Humans
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The pharmacokinetics of the novel promotile drug, tegaserod, are similar in healthy subjects-male an...
Next Document:  High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepa...